Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors

• Authors: MOYSIADIS T.; BALIAKAS P.; ROSSI D.; CATHERWOOD M.; STREFFORD J.C.; DELGADO J.; ANAGNOSTOPOULOS A.; BELESSI C.; STAVROYIANNI N.; POSPÍŠILOVÁ Šárka; OSCIER D.; GAIDANO G.; CAMPO E.; ROSENQUIST R.; GHIA P.; STAMATOPOULOS K.
• Year of publication: 2019
• Type: Article in Periodical
• Magazine / Source: Leukemia
• MU Faculty or unit: Central European Institute of Technology
• Web: https://www.nature.com/articles/s41375-018-0322-7
• Doi: http://dx.doi.org/10.1038/s41375-018-0322-7
• Keywords: SURVIVAL

Attached files

• Figures_and_Tables_Hazard_paper__supplemental__181024_final.docx
• Figures_and_Tables_Hazard_paper__supplemental__181024_final.pdf
• Hazard_paper_20180807_ref.docx
• Hazard_paper_revised_ref_181024_final.docx

• Description: Chronic lymphocytic leukemia (CLL) displays remarkable clinical heterogeneity, likely attributed to the underlying biological diversity. This claim is supported by the fact that certain immunogenetic and/or genomic features identify subgroups of CLL patients with distinct prognosis and outcome.

Related projects

• MEDGENET - Medical genomics and epigenomics network
• CEITEC 2020